KP
GILD icon

Keel Point’s Gilead Sciences GILD Stock Holding History

Keel Point’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$920K Sell
6,604
-868
-12% -$122K 0.06% 180
2025
Q4 		$917K Buy
7,472
+1,449
+24% +$176K 0.06% 196
2025
Q3 		$669K Sell
6,023
-175
-3% -$19.9K 0.04% 243
2025
Q2 		$687K Buy
6,198
+259
+4% +$27.6K 0.05% 234
2025
Q1 		$665K Buy
5,939
+1,578
+36% +$163K 0.05% 197
2024
Q4 		$403K Sell
4,361
-404
-8% -$36.4K 0.03% 271
2024
Q3 		$399K Buy
4,765
+1,368
+40% +$104K 0.03% 279
2024
Q2 		$251K Buy
+3,397
New +$227K 0.02% 358
2020
Q2 		– Sell
-3,338
Closed -$250K – 193
2020
Q1 		$250K Buy
+3,338
New +$231K 0.03% 152
2017
Q3 		– Sell
-3,123
Closed -$221K – 166
2017
Q2 		$221K Buy
3,123
+12
+0.4% +$799 0.04% 145
2017
Q1 		$211K Buy
3,111
+11
+0.4% +$773 0.04% 150
2016
Q4 		$222K Buy
+3,100
New +$230K 0.05% 143

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Keel Point's GILD Position: Q1 2026 in Review

Keel Point reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $122K and leaving 6,604 shares worth $920K. The position accounts for 0.06% of the portfolio, ranked #180.

Keel Point first reported a position in GILD in Q4 2016 and has held it in 12 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Keel Point held 6,604 shares of Gilead Sciences worth $920K as of Q1 2026.
  • Keel Point sold 868 Gilead Sciences shares in Q1 2026, an estimated $122K.
  • Gilead Sciences made up 0.06% of Keel Point's portfolio in Q1 2026, its #180 holding.
  • Keel Point first reported a position in Gilead Sciences in Q4 2016 and has held it in 12 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.